Cardiology

Ranexa^® is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as Beta-blockers and/or Calcium antagonists).

Clinical evidence for Ranexa^® (ranolazine) for stable angina pectoris demonstrating the safety and efficacy of Ranexa^® | For UK Healthcare professionals only

Learn about stable angina and the management of stable angina pectoris. For UK healthcare professionals only.